Who
Anne S. Drapeau
Director
Company insider
Files Form 4 as: Director, Vaxcyte; EVP, Strategy and Talent, Iron Mountain Incorporated (Delaware); Executive VP and CPO, Cimpress.
In numbers
- Trades disclosed
- 89
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $4.7M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 4 Aug 2006
- Last trade
- 15 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 16 Jun 2026 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —2,265 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,389 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,389 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —2,265 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,372 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —3,041 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,250 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —1,550 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,750 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —3,125 at $0.00 | filing |
| 16 Sep 2021filed 24 Sep 2021 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 16 Mar 2015filed 18 Mar 2015 | IRM Iron Mountain Incorporated (Delaware)REITs | SEC FORM 4 Code M | —3,476 at $0.00 | filing |
| 16 Mar 2015filed 18 Mar 2015 | IRM Iron Mountain Incorporated (Delaware)REITs | SEC FORM 4 Code F | $42K1,129 at $37.38 | filing |
| 16 Mar 2015filed 18 Mar 2015 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code M | —3,476 at $0.00 | filing |
| 10 Mar 2015filed 11 Mar 2015 | IRM Iron Mountain Incorporated (Delaware)REITs | SEC FORM 4 Sold | $185K5,090 at $36.29 | filing |
| 9 Mar 2015filed 11 Mar 2015 | IRM Iron Mountain Incorporated (Delaware)REITs | SEC FORM 4 Code M | —11,042 at $0.00 | filing |
| 9 Mar 2015filed 11 Mar 2015 | IRM Iron Mountain Incorporated (Delaware)REITs | SEC FORM 4 Code F | $133K3,648 at $36.42 | filing |
| 9 Mar 2015filed 11 Mar 2015 | IRM Iron Mountain Incorporated (Delaware)REITs | SEC FORM 4 Code M | —4,127 at $0.00 | filing |
News
Head to Head Review: Cimpress (NASDAQ:CMPR) & Vestis (NYSE:VSTS)CMPR · dailypolitical.com · 18 Oct 2026Vestis (NYSE:VSTS) vs. Cimpress (NASDAQ:CMPR) Financial ContrastCMPR · tickerreport.com · 18 Oct 2026Insider Selling: Iron Mountain (NYSE:IRM) EVP Sells $553,600.00 in StockIRM · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Anne S. Drapeau; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.